arrow_back Back to App

Easier Access to COVID-19 Drugs: Hospitals Order Directly

This new law aims to make it easier for hospitals and medical facilities to directly order COVID-19 medications, known as monoclonal antibody therapies, from manufacturers. This means medical facilities will no longer need to go through state governments to obtain these drugs, potentially speeding up their availability for patients.
Key points
Hospitals and medical facilities can order COVID-19 drugs directly from manufacturers, bypassing state authorities.
The previous policy requiring drug orders through state governments is nullified.
The goal is faster and easier access to monoclonal antibody therapies for COVID-19 patients.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5663
Sponsor: Rep. Harshbarger, Diana [R-TN-1]
Process start date: 2021-10-21
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

TREAT Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5663.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-10-21.

What are the main provisions?

Key points include:

  • Hospitals and medical facilities can order COVID-19 drugs directly from manufacturers, bypassing state authorities.
  • The previous policy requiring drug orders through state governments is nullified.
  • The goal is faster and easier access to monoclonal antibody therapies for COVID-19 patients.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Harshbarger, Diana [R-TN-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health